885498-48-6 Usage
Description
4-N-BOC-AMINO-4-TETRAHYDROPYRANCARBOXYLIC ACID METHYL ESTER is a chemical compound that belongs to the class of amino acids and carboxylic acid esters. It is a derivative of tetrahydropyran carboxylic acid, which is commonly used in the synthesis of pharmaceuticals and other organic compounds. The "BOC" in the name refers to the tert-butyloxycarbonyl protecting group, which is often used in organic synthesis to protect specific functional groups from undesired reactions.
Uses
Used in Pharmaceutical Synthesis:
4-N-BOC-AMINO-4-TETRAHYDROPYRANCARBOXYLIC ACID METHYL ESTER is used as an intermediate in the synthesis of pharmaceuticals for its ability to provide a protected form of tetrahydropyran carboxylic acid, facilitating the development of new drugs.
Used in Organic Chemistry:
In the field of organic chemistry, 4-N-BOC-AMINO-4-TETRAHYDROPYRANCARBOXYLIC ACID METHYL ESTER is used as a building block for the synthesis of complex organic compounds, taking advantage of its unique structure and the protective BOC group to control reaction pathways.
Used in Medicinal Chemistry Research:
4-N-BOC-AMINO-4-TETRAHYDROPYRANCARBOXYLIC ACID METHYL ESTER is utilized as a research compound in medicinal chemistry, where it aids chemists and researchers in understanding the structure-activity relationships of potential drug candidates and in the optimization of their pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 885498-48-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,4,9 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 885498-48:
(8*8)+(7*8)+(6*5)+(5*4)+(4*9)+(3*8)+(2*4)+(1*8)=246
246 % 10 = 6
So 885498-48-6 is a valid CAS Registry Number.
885498-48-6Relevant articles and documents
CYCLYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
-
Page/Page column 16, (2009/10/31)
Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type and/or T-type calcium channel activity are disclosed. Specifically, a series of compounds of substituted or unsubstituted cyclylamine derivatives as shown in formulas (1).
